Now showing items 27-46 of 314

      Cardiometabolic Safety of Atypical Antipsychotic Medications among Publicly Insured U.S. Youth [1]
      Characterization of beta-cyclodextrin for direct compression tableting. [1]
      Characterization of Heme Transport in Pseudomonas aeruginosa and the Preferential Pathway for Heme Uptake [1]
      The characterization of heterogeneous surfaces using modified immersional calorimetry [1]
      Characterization of pharmacokinetic and pharmacodynamic drug interactions of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) [1]
      Characterization of the pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in humans and dogs [1]
      Cholinergic pharmacology of tetrahydroaminoacridine (THA or Tacrine(registered trademark)) [1]
      Clinical and economic impact of statin therapy compliance on hyperlipidemic patients with concomitant CHD risk factors [1]
      Clinical and Environmental Harmonization to Enhance Absorptive Predictability from Complex Dermal Products: In Vitro Permeation Testing to Healthy Volunteers [1]
      The cloning and identification of a streptonigrin resistance gene from Escherichia coli [1]
      A Cluster Analytic Approach to Identify Insomnia Subtypes and Their Relationship with Economic Outcomes [1]
      Community Treatment Patterns for Pediatric Hypertension in Medicaid-insured Youth [1]
      A comparative study of the formulation requirements of dosator and dosing disc encapsulators, simulation of plug formation, and creation of rules for an expert system for formulation design [1]
      Computer-assisted analysis of structure-activity relationships of philanthotoxin analogues [1]
      Contextual Analysis of the Effect of Prostate-Specific Antigen Testing on Prostate Cancer Outcomes among Elderly Men [1]
      Contributions of dissolution and intestinal permeation to oral drug product quality [1]
      Correlates of psychopharmacologic treatment outcomes for schizophrenia [1]
      Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy [1]
      Costs, outcomes and estimation of the cost-effectiveness of abciximab in the prevention of ischemic events over six months of follow-up [1]
      CPSF30:A Zinc Finger Protein With An Iron-Sulfur Site [1]